The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G(2)/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells

Documenti analoghi

• Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway
  di: Niu, Ning-Kui, et al.
  Pubblicazione: (2015)
• MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors
  di: Sells, Todd B., et al.
  Pubblicazione: (2015)
• Alisertib induces G(2)/M arrest, apoptosis, and autophagy via PI3K/Akt/mTOR- and p38 MAPK-mediated pathways in human glioblastoma cells
  di: Liu, Zheng, et al.
  Pubblicazione: (2017)
• Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway
  di: Niu NK, et al.
  Pubblicazione: (2015-03-01)
• Plumbagin induces G(2)/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells
  di: Pan, Shu-Ting, et al.
  Pubblicazione: (2015)